Female Dorsal Buccal Mucosal Graft Urethroplasty: Implications for Urinary Continence and Sexual Function

ArticleAçık Erişim

Özet

Introduction: Dorsal buccal mucosal graft urethroplasty (DBMGU) is an established surgical approach for female urethral stricture. However, its functional outcomes, particularly those related to sexual function, de novo urinary incontinence, and coital incontinence, have not been comprehensively evaluated. Objectives: To evaluate the outcomes of DBMGU with respect to female sexual function, de novo urinary incontinence, and coital incontinence, in addition to overall surgical success. Methods: This prospective, nonrandomized cohort study included sexually active women who underwent DBMGU. Preoperative evaluation included uroflowmetry (UF) and the Female Sexual Function Index (FSFI). Operative data, including perioperative complications and postoperative pain measured using the Visual Analog Scale (VAS) on the first postoperative day, were recorded. At 6 months postoperatively, all patients underwent repeat UF and completed the FSFI, the 3 Incontinence Questions (3IQ) to assess de novo urinary incontinence, and the Patient Global Impression of Improvement (PGI-I) to assess subjective outcomes. Data regarding de novo coital incontinence were noted, and the need for any additional intervention due to recurrent urethral stricture was collected to determine the objective cure. Results: A total of 27 patients were included, with a median age of 42 years (range: 22–56) and a median follow-up period of 3 years (range: 6 months–6 years). Two patients had suprapubic cystostomy before surgery; the remaining 25 patients had a median preoperative Qmax of 6 mL/s (range: 2–10). The median operative time was 65 min (range: 45–90), and the median operative VAS score was 6 (range: 3–8). Two patients experienced Clavien–Dindo Grade II complications (one vaginitis and one severe urinary urgency), and one patient experienced a Clavien–Dindo Grade III complication due to bleeding at the graft harvest site, which was treated with bipolar cauterization. The median postoperative Qmax increased to 25 mL/s (range: 8–35). One patient required a single endoscopic dilatation for recurrence, resulting in an objective cure rate of 96.2%. One patient reported a PGI-I score of 5; the remaining 26 patients had a median PGI-I score of 2 (range: 1–2), corresponding to a subjective cure rate of 96.2%. All patients were continent according to the first item of the 3IQ, and no cases of de novo coital incontinence were reported. No statistically significant differences were observed between preoperative and postoperative total FSFI scores or most domain-specific subscores, except for a change in the desire domain (p = 0.01). Conclusion: Dorsal onlay buccal mucosal graft urethroplasty shows high objective and subjective cure rates in women with female urethral stricture disease (FUSD). Our findings suggest that this procedure does not significantly impair sexual function or cause de novo urinary incontinence. © 2026 Wiley Periodicals LLC.

Anahtar Kelimeler

RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/ebyu/10455Resmi atıflarda kullanılan kalıcı adres
DOI
https://doi.org/10.1002/nau.70420Yayıncı resmi DOI adresi
Tam Kayıt
AlanDeğerDil
dc.contributor.authorÇubuk, Alkan
dc.contributor.authorÇıtamak, Burak
dc.contributor.authorDoğan, Çağrı
dc.contributor.authorBaşer, Aykut
dc.contributor.authorBalaban, Muhsin
dc.contributor.authorÇalışkan, Selahattin
dc.contributor.authorOzkaptan, Orkunt
dc.contributor.authorŞahan, Ahmet
dc.date.accessioned2026-10-18T20:25:40.177541278Z
dc.date.available2026-10-18T20:25:40.177541278Z
dc.date.issued2026
dc.description.abstractIntroduction: Dorsal buccal mucosal graft urethroplasty (DBMGU) is an established surgical approach for female urethral stricture. However, its functional outcomes, particularly those related to sexual function, de novo urinary incontinence, and coital incontinence, have not been comprehensively evaluated. Objectives: To evaluate the outcomes of DBMGU with respect to female sexual function, de novo urinary incontinence, and coital incontinence, in addition to overall surgical success. Methods: This prospective, nonrandomized cohort study included sexually active women who underwent DBMGU. Preoperative evaluation included uroflowmetry (UF) and the Female Sexual Function Index (FSFI). Operative data, including perioperative complications and postoperative pain measured using the Visual Analog Scale (VAS) on the first postoperative day, were recorded. At 6 months postoperatively, all patients underwent repeat UF and completed the FSFI, the 3 Incontinence Questions (3IQ) to assess de novo urinary incontinence, and the Patient Global Impression of Improvement (PGI-I) to assess subjective outcomes. Data regarding de novo coital incontinence were noted, and the need for any additional intervention due to recurrent urethral stricture was collected to determine the objective cure. Results: A total of 27 patients were included, with a median age of 42 years (range: 22–56) and a median follow-up period of 3 years (range: 6 months–6 years). Two patients had suprapubic cystostomy before surgery; the remaining 25 patients had a median preoperative Qmax of 6 mL/s (range: 2–10). The median operative time was 65 min (range: 45–90), and the median operative VAS score was 6 (range: 3–8). Two patients experienced Clavien–Dindo Grade II complications (one vaginitis and one severe urinary urgency), and one patient experienced a Clavien–Dindo Grade III complication due to bleeding at the graft harvest site, which was treated with bipolar cauterization. The median postoperative Qmax increased to 25 mL/s (range: 8–35). One patient required a single endoscopic dilatation for recurrence, resulting in an objective cure rate of 96.2%. One patient reported a PGI-I score of 5; the remaining 26 patients had a median PGI-I score of 2 (range: 1–2), corresponding to a subjective cure rate of 96.2%. All patients were continent according to the first item of the 3IQ, and no cases of de novo coital incontinence were reported. No statistically significant differences were observed between preoperative and postoperative total FSFI scores or most domain-specific subscores, except for a change in the desire domain (p = 0.01). Conclusion: Dorsal onlay buccal mucosal graft urethroplasty shows high objective and subjective cure rates in women with female urethral stricture disease (FUSD). Our findings suggest that this procedure does not significantly impair sexual function or cause de novo urinary incontinence. © 2026 Wiley Periodicals LLC.
dc.identifier.doi10.1002/nau.70420
dc.identifier.eissn1520-6777
dc.identifier.issn0733-2467
dc.identifier.pmid42621747
dc.identifier.scopus2-s2.0-105047738466
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/ebyu/10455
dc.identifier.wosWOS:001853715500001
dc.language.isoen
dc.publisherJohn Wiley and Sons Inc
dc.relation.ispartofNeurourology and Urodynamics
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectdorsal buccal mucosal graft
dc.subjectfemale urethroplasty
dc.subjectsexual function
dc.subjecturethral stricture
dc.subjecturinary incontinence
dc.titleFemale Dorsal Buccal Mucosal Graft Urethroplasty: Implications for Urinary Continence and Sexual Function
dc.typeArticle
dspace.entity.typePublication
rdl.citation.scopus0
rdl.citation.wos0
rdl.departmentDepartment of Urology, Mengücek Gazi Training and Research Hospital, Erzincan University, Erzincan, Turkey.
rdl.source.indexSCOPUS
rdl.source.indexWOS
rdl.source.indexPUBMED
rdl.wos.indexScience Citation Index Expanded (SCI-EXPANDED)